Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Deborah D. Murphy, Michael R. Nelson, Thomas A.E. Platts‐Mills, Jeffrey M. Wilson
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Booster (rocketry)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyVaccination2019-20 coronavirus outbreakBooster doseMessenger RNAImmunologyVirusOutbreakInfectious disease (medical specialty)Internal medicineTiterGeneChemistryBiochemistryPhysicsAstronomyDiseaseSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies